GAXOS.AI Reports Increased Losses, Significant Dilution from $5.4M ATM Sales, and Strategic Defense AI Acquisition
GXAI sits 35% above its 52-week low of $1 on light trading volume (0.1× avg).
Summary
GAXOS.AI reported increased losses for FY2025 despite revenue growth. Post-year-end, the company raised $5.4 million through highly dilutive ATM share sales and made a $2.9 million strategic acquisition in defense AI, while facing Nasdaq delisting risks.
Key Events · Financing and Capital Events · GXAI
-
Increased Net Loss for FY2025
The company reported a net loss of $4.28 million for the fiscal year ended December 31, 2025, an increase from $3.42 million in the prior year.
-
Significant Revenue Growth
Revenues surged to $1.93 million in 2025 from $4,027 in 2024, primarily from RNK Health administrative services and Gaxos Labs subscriptions.
-
Highly Dilutive ATM Share Sales
Between January 26, 2026, and March 5, 2026, GAXOS.AI issued 3,096,481 common shares through its ATM program, raising approximately $5.4 million. This represents over 30% dilution to the current outstanding shares.
-
Strategic Acquisition in Defense AI
On March 4, 2026, the company completed the purchase of a 19.99% membership interest in America First Defense.AI LLC for $2.9 million, expanding its portfolio into the defense sector.
Analysis · GXAI · Technology
GAXOS.AI's annual report for fiscal year 2025 reveals a substantial increase in net loss to $4.28 million, up from $3.42 million in 2024, despite a significant revenue jump from $4,027 to $1.93 million, primarily driven by RNK Health and Gaxos Labs subscriptions. The company's cash used in operations also increased to $3.85 million. Critically, subsequent events disclosed include the issuance of 3,096,481 common shares between January 26, 2026, and March 5, 2026, raising $5.4 million through its At-The-Market (ATM) program. This represents a highly dilutive event, increasing outstanding shares by over 30%. Additionally, the company completed a $2.9 million acquisition of a 19.99% stake in America First Defense.AI LLC on March 4, 2026, marking a significant strategic investment. The filing also highlights ongoing risks, including the need for additional financing and the potential for Nasdaq delisting, which could severely impact liquidity and investor confidence.
At the time of this filing, GXAI was trading at $1.35 on NASDAQ in the Technology sector, with a market capitalization of approximately $11.7M. The 52-week trading range was $1.00 to $2.96. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.